• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    11/27/23 1:41:21 PM ET
    $AAOI
    $AFRM
    $APLM
    $ASST
    Semiconductors
    Technology
    Finance: Consumer Services
    Finance
    Get the next $AAOI alert in real time by email

    Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.

    The company posted a quarterly net loss of $10.1 million, inclusive of $3.2 million in non-cash items, or 12 cents per share for the fourth quarter, versus a year-ago net loss of $14.3 million, inclusive of $6.0 million in non-cash items, or 18 cents per share for the year-ago period.

    Anavex Life Sciences shares fell 10% to $6.35 on Monday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • RedHill Biopharma Ltd. (NASDAQ:RDHL) shares climbed 125% to $0.7063 after the company announced the FDA has granted five years' market exclusivity for Talicia.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) gained 122.8% to $5.96 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.
    • Tharimmune, Inc. (NASDAQ:THAR) shares climbed 48.6% to $4.28 after the company reported Phase 1 data on TH104 for chronic pruritis in primary biliary cholangitis.
    • Asset Entities Inc. (NASDAQ:ASST) gained 34% to $0.4703 after the company announced a stock repurchase program.
    • Captivision Inc. (NASDAQ:CAPT) rose 20.1% to $2.81 after surging 44% on Friday.
    • Perfect Corp. (NYSE:PERF) climbed 19.7% to $2.9944. The company on Monday announced the commencement of a tender offer to purchase shares above the current share price.
    • IO Biotech, Inc. (NASDAQ:IOBT) gained 19% to $1.3988. IO Biotech Chief Accounting Officer Brian Burkavage acquired a total of 10,000 shares at an average price of $1.01.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) gained 18.4% to $0.6680 after the company announced FDA clearance of the Phase 1B IND for TCB-008 in Acute Myeloid Leukemia.
    • Apollomics, Inc. (NASDAQ:APLM) shares rose 18.3% to $1.1750 after surging 14% on Friday. The company’s partner in China, Avistone Biotechnology Co. Ltd., recently received conditional approval from the National Medical Products Administration (NMPA) of China for the commercialization of vebreltinib to treat patients with MET exon 14 skipping non-small cell lung cancer (NSCLC).
    • Safety Shot, Inc. (NASDAQ:SHOT) gained 17.8% to $4.2782.
    • ClearSign Technologies Corporation (NASDAQ:CLIR) gained 16% to $1.5665.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) jumped 13.7% to $29.82 following reports of record 'buy now, pay later' predictions on Cyber Monday.
    • MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) rose 13% to $3.72.
    • Oxbridge Re Holdings Limited (NASDAQ:OXBR) gained 12.5% to $1.2156.
    • IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:IRS) rose 12.4% to $9.13.
    • EHang Holdings Limited (NASDAQ:EH) gained 12.1% to $19.71.
    • Ituran Location and Control Ltd. (NASDAQ:ITRN) climbed 11.3% to $27.69 after the company reported third-quarter financial results.
    • Xenon Pharmaceuticals Inc. (NASDAQ:XENE) rose 10.2% to $31.93 after the company announced topline results from the Phase 2 proof-of-concept X-NOVA clinical trial of XEN1101 in MDD.
    • Applied Optoelectronics, Inc. (NASDAQ:AAOI) gained 8.8% to $14.19.
    • Telecom Argentina S.A. (NYSE:TEO) rose 6.7% to $8.26.

    Losers

    • 10X Capital Venture Acquisition Corp. II (NASDAQ:VCXA) shares dipped 21.2% to $8.39.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) fell 19.5% to $0.7246 after jumping 144% on Friday.
    • HCW Biologics Inc. (NASDAQ:HCWB) declined 14.5% to $1.00.
    • SharpLink Gaming Ltd. (NASDAQ:SBET) fell 14.4% to $1.49.
    • Innodata Inc. (NASDAQ:INOD) fell 14.2% to $5.80.
    • Reliance Global Group, Inc. (NASDAQ:RELI) declined 14% to $1.04.
    • SenesTech, Inc. (NASDAQ:SNES) fell 13.6% to $1.8738.
    • B. Riley Financial, Inc. (NASDAQ:RILY) dropped 11.2% to $18.61.
    • Puyi Inc. (NASDAQ:PUYI) declined 10.8% to $3.53.
    • TMC the metals company Inc. (NASDAQ:TMC) fell 10% to $1.2595.
    • HUYA Inc. (NYSE:HUYA) fell 7.4% to $3.5650.
    • Fisker Inc. (NYSE:FSR) declined 6.7% to $2.08.
    • Chewy, Inc. (NYSE:CHWY) fell 6.6% to $18.94.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) fell 5.8% to $1.29 after the company said Michael Kurlander, Chief Financial Officer, has stepped down from his role to pursue an outside opportunity. The company named Deputy Chief Financial Officer Evangelos Perros as Interim Chief Financial Officer.
    • Polaris Inc. (NYSE:PII) fell 4% to $86.96.

    Now Read This: Bitcoin Falls Below $37,000; Blur, Gas Among Top Losers

    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $AFRM
    $APLM
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    Applied Optoelectronics Inc.
    $AAOI
    2/27/2026$55.00Outperform → Market Perform
    Northland Capital
    Applied Optoelectronics Inc.
    $AAOI
    2/27/2026$54.00Sell → Neutral
    B. Riley Securities
    Xenon Pharmaceuticals Inc.
    $XENE
    2/24/2026$60.00Outperform
    Wolfe Research
    Affirm Holdings Inc.
    $AFRM
    2/20/2026$55.00Neutral
    Robert W. Baird
    Chewy Inc.
    $CHWY
    2/19/2026$28.00Mkt Perform → Outperform
    Raymond James
    Affirm Holdings Inc.
    $AFRM
    2/3/2026$76.00Equal-Weight → Overweight
    Morgan Stanley
    IRSA Inversiones Y Representaciones S.A.
    $IRS
    1/30/2026$23.00Outperform
    Itau BBA
    Sharplink Inc.
    $SBET
    1/29/2026$16.00Buy
    Canaccord Genuity
    More analyst ratings

    $AAOI
    $AFRM
    $APLM
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Chief Financial Officer Pham Benjamin bought $115,095 worth of shares (14,114 units at $8.15) (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    2/19/26 8:00:23 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Chief Legal Officer Beirne Brian Logan bought $100,387 worth of shares (11,500 units at $8.73), increasing direct ownership by 310% to 15,204 units (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    2/17/26 8:02:53 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $AAOI
    $AFRM
    $APLM
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Deppe Christopher S. covered exercise/tax liability with 1,976 shares and sold $81,765 worth of shares (3,043 units at $26.87), decreasing direct ownership by 63% to 1,566 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    3/3/26 6:10:33 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    General Counsel & Secretary Hu Da-Wai covered exercise/tax liability with 1,777 shares, decreasing direct ownership by 18% to 8,149 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    3/3/26 6:03:43 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    New insider Deppe Christopher S. claimed ownership of 52,336 shares (SEC Form 3)

    3 - Chewy, Inc. (0001766502) (Issuer)

    3/3/26 5:58:22 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AAOI
    $AFRM
    $APLM
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Applied Optoelectronics downgraded by Northland Capital with a new price target

    Northland Capital downgraded Applied Optoelectronics from Outperform to Market Perform and set a new price target of $55.00

    2/27/26 8:26:41 AM ET
    $AAOI
    Semiconductors
    Technology

    Applied Optoelectronics upgraded by B. Riley Securities with a new price target

    B. Riley Securities upgraded Applied Optoelectronics from Sell to Neutral and set a new price target of $54.00

    2/27/26 8:19:46 AM ET
    $AAOI
    Semiconductors
    Technology

    Wolfe Research initiated coverage on Xenon Pharmaceuticals with a new price target

    Wolfe Research initiated coverage of Xenon Pharmaceuticals with a rating of Outperform and set a new price target of $60.00

    2/24/26 7:57:17 AM ET
    $XENE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $AFRM
    $APLM
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Affirm to host CFO fireside chat on March 17, 2026

    Affirm invites investors to submit questions for the fireside chat Affirm Holdings, Inc. (NASDAQ:AFRM) ("Affirm" or the "Company") today announced that Rob O'Hare, CFO, will participate in a shareholder fireside chat on Tuesday, March 17, 2026. The discussion will be moderated by Harry Bartlett from Rothschild & Co Redburn and will begin at 9:00 AM Pacific Time. The event will be webcast live on the Company's investor relations website at https://investors.affirm.com, and management will address a selection of the top questions from retail and institutional shareholders relating to Affirm's strategy, products, business model, and financial results. Affirm will also be using Say Techno

    3/3/26 4:07:00 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Affirm expands Stripe partnership to support Shared Payment Tokens for agentic commerce

    Enables secure, transparent pay-over-time options within AI-driven shopping experiences Affirm (NASDAQ:AFRM) is expanding its long-standing partnership with Stripe to soon support Shared Payment Tokens (SPT), which let AI agents initiate purchases using a shopper's permission and preferred payment method without exposing sensitive credentials. The collaboration will soon bring Affirm's pay-over-time options to checkout in AI-driven commerce experiences, so shoppers can see the total cost upfront and select a clear repayment plan even when an AI assistant is helping them browse and buy. Meanwhile, merchants will be able to accept those payments on the backend through Stripe. "Commerce

    3/3/26 9:00:00 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Anavex Life Sciences to Present at the Citizens Life Sciences Conference

    NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that Christopher U Missling, PhD, President & Chief Executive Officer, will present at the Citizens Life Sciences Conference on Tuesday, March 10th, 2026 at 11:55 AM (ET). About Anavex Life Sciences Corp. Anavex Life Sciences Corp. (NASDAQ:AVXL) is a publicly traded biopharmaceutical

    3/3/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $AFRM
    $APLM
    $ASST
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AAOI
    $AFRM
    $APLM
    $ASST
    SEC Filings

    View All

    BRC Group Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - BRC Group Holdings, Inc. (0001464790) (Filer)

    3/3/26 5:00:22 PM ET
    $RILY
    Investment Managers
    Finance

    SEC Form PRE 14A filed by HCW Biologics Inc.

    PRE 14A - HCW Biologics Inc. (0001828673) (Filer)

    3/3/26 4:15:18 PM ET
    $HCWB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MIRA Pharmaceuticals Inc. filed SEC Form 8-K: Other Events

    8-K - MIRA PHARMACEUTICALS, INC. (0001904286) (Filer)

    3/3/26 4:01:24 PM ET
    $MIRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $AFRM
    $APLM
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    Chewy Appoints Chris Deppe as Chief Financial Officer

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a leading and trusted destination for pet parents and partners everywhere, announced today the appointment of Chris Deppe as Chief Financial Officer (CFO). Deppe is a seasoned finance and operations leader with more than 20 years of experience. He joined Chewy in 2022 as the Vice President of Supply Chain and Operations Finance, and most recently served as the Head of all Corporate and Commercial Finance Functions. During his tenure, he has played a key role in advancing the company's financial strategy, enhancing operational rigor, and supporting strong business performance aligned with Chewy's long-term strategic priorities. Prior to joining Chewy, D

    2/24/26 9:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced the appointment of Dr. Axel Paeger, MD, MBA, MBI to its Board of Directors. "We are delighted to welcome Dr. Paeger to our Board of Directors at Anavex," said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. "Dr. Paeger brings three decades of strong leade

    2/23/26 7:30:00 AM ET
    $AVXL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $AFRM
    $APLM
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Innodata Inc.

    SC 13D/A - INNODATA INC (0000903651) (Subject)

    11/26/24 5:19:30 PM ET
    $INOD
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by HCW Biologics Inc.

    SC 13D/A - HCW Biologics Inc. (0001828673) (Subject)

    11/22/24 4:53:35 PM ET
    $HCWB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/20/24 11:56:39 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $AFRM
    $APLM
    $ASST
    Financials

    Live finance-specific insights

    View All

    Chewy Announces Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal fourth quarter and full year 2025 financial results before the market opens on Wednesday, March 25, 2026. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcas

    3/2/26 7:30:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Applied Optoelectronics Reports Fourth Quarter and Full Year 2025 Results

    SUGAR LAND, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ:AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power the internet, today announced financial results for its fourth quarter and full year ended December 31, 2025. "We are pleased to deliver record fourth quarter results that were in line with or better than our expectations, and which capped off the strongest year in our company's history," said Dr. Thompson Lin, AOI's Founder, President and Chief Executive Officer. "Our results were driven by broad-based demand in both our CATV and datacenter businesses. We have considerable momentum entering 2026, and we b

    2/26/26 4:10:00 PM ET
    $AAOI
    Semiconductors
    Technology

    Sharplink to Host Full Year 2025 Earnings Conference Call and Webcast on March 9, 2026 at 8:30 A.M. E.T.

    MIAMI, FL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharplink, Inc. (NASDAQ:SBET) ("Sharplink" or the "Company"), one of the world's largest corporate holders of Ether ("ETH") and prominent industry advocate of Ethereum adoption, today announced that the Company will host a conference call on Monday, March 9, 2026 at 8:30 A.M. Eastern Time to discuss its financial and operating results for the full year ended December 31, 2025. The Company will release its financial results in a press release prior to the call. Sharplink's executive team will host the conference call, followed by a question-and-answer period. The conference call details are as follows: Date: Monday, March 9, 2026Time: 8:30 A.M.

    2/25/26 8:00:00 AM ET
    $SBET
    Computer Software: Prepackaged Software
    Technology